Cargando…

Cell-Based Therapies for Stroke: Are We There Yet?

Stroke is the second leading cause of death and physical disability, with a global lifetime incidence rate of 1 in 6. Currently, the only FDA approved treatment for ischemic stroke is the administration of tissue plasminogen activator (tPA). Stem cell clinical trials for stroke have been underway fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krause, Mirja, Phan, Thanh G., Ma, Henry, Sobey, Christopher G., Lim, Rebecca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603096/ https://www.ncbi.nlm.nih.gov/pubmed/31293500 http://dx.doi.org/10.3389/fneur.2019.00656

Ejemplares similares

Acute Stroke Biomarkers: Are We There Yet?
por: Dagonnier, Marie, et al.
Publicado: (2021)

Phase 1 Trial of Amnion Cell Therapy for Ischemic Stroke
por: Phan, Thanh G., et al.
Publicado: (2018)

Googling Location for Operating Base of Mobile Stroke Unit in Metropolitan Sydney
por: Phan, Thanh G., et al.
Publicado: (2019)

Amnion epithelial cells – a novel therapy for ischemic stroke?
por: Evans, Megan A., et al.
Publicado: (2018)

Improving Technology to Diagnose Tuberculous Meningitis: Are We There Yet?
por: Ssebambulidde, Kenneth, et al.
Publicado: (2022)

Network Mapping of Time to Antithrombotic Therapy Among Patients With Ischemic Stroke and Transient Ischemic Attack (TIA)
por: Phan, Thanh G., et al.
Publicado: (2021)

Googling Boundaries for Operating Mobile Stroke Unit for Stroke Codes
por: Phan, Thanh G., et al.
Publicado: (2019)

Googling the Lifetime Risk of Stroke Around the World
por: Phan, Thanh G., et al.
Publicado: (2020)

Stroke Severity Versus Dysphagia Screen as Driver for Post-stroke Pneumonia
por: Phan, Thanh G., et al.
Publicado: (2019)

Corrigendum: Phase I trial outcome of amnion cell therapy in patients with ischemic stroke (I-ACT)
por: Phan, Thanh G., et al.
Publicado: (2023)

Application of Strategic Transport Model and Google Maps to Develop Better Clot Retrieval Stroke Service
por: Tajaddini, Atousa, et al.
Publicado: (2019)

Editorial: Geospatial and Transport Modeling in Stroke Service Planning
por: Phan, Thanh G., et al.
Publicado: (2019)

Impact of corticofugal fibre involvement in subcortical stroke
por: Phan, Thanh G, et al.
Publicado: (2013)

A Rare, Unreported Cognitive Side Effect of Topiramate: Do We Know It All Yet?
por: Karim, Nurose, et al.
Publicado: (2020)

Concise Review: Stem Cell Therapy for Stroke Patients: Are We There Yet?
por: Borlongan, Cesario V.
Publicado: (2019)

Assessing the diagnostic accuracy of CT perfusion: a systematic review
por: Thirugnanachandran, Tharani, et al.
Publicado: (2023)

Editorial: Machine Learning in Action: Stroke Diagnosis and Outcome Prediction
por: Abedi, Vida, et al.
Publicado: (2022)

Protection against brain injury after ischemic stroke by intravenous human amnion epithelial cells in combination with tissue plasminogen activator
por: Barreto-Arce, Liz J., et al.
Publicado: (2023)

Googling Service Boundaries for Endovascular Clot Retrieval (ECR) Hub Hospitals in Metropolitan Sydney
por: Phan, Thanh G., et al.
Publicado: (2019)

Can Helicopters Solve the Transport Dilemma for Patients With Symptoms of Large-Vessel Occlusion Stroke in Intermediate Density Areas? A Simulation Model Based on Real Life Data
por: Behrndtz, Anne, et al.
Publicado: (2022)

An Introduction to Software Tools, Data, and Services for Geospatial Analysis of Stroke Services
por: Padgham, Mark, et al.
Publicado: (2019)

Rehabilitation: a key service, yet highly underused, in the management of young patients with sickle cell disease after stroke in DR of Congo
por: Boma, Paul Muteb, et al.
Publicado: (2023)

Mapping topography and network of brain injury in patients with disorders of consciousness
por: Liyana Arachige, Manoj, et al.
Publicado: (2023)

Are we there yet?
por: Swann, Nicole
Publicado: (2019)

Are we there yet?
por: Wise, Jo Ann
Publicado: (2015)

Are we there yet?
por: McCann, Shaun R.
Publicado: (2022)

The Role of Stem Cells in the Therapy of Stroke
por: Ejma, Maria, et al.
Publicado: (2022)

Drug Therapy for Obstructive Sleep Apnea: Are We There Yet?
por: Schmickl, Christopher N., et al.
Publicado: (2022)

Computer Modeling of Clot Retrieval—Circle of Willis
por: Phan, Thanh G., et al.
Publicado: (2020)

Stem-cell therapy for hearing loss: are we there yet?()
por: Dufner-Almeida, Luiz Gustavo, et al.
Publicado: (2019)

Cancer vaccines: Are we there yet?
por: Hanna, Jr., Michael G.
Publicado: (2012)

Phase I trial outcome of amnion cell therapy in patients with ischemic stroke (I-ACT)
por: Phan, Thanh G., et al.
Publicado: (2023)

Spatiotemporal analysis of regional TIA trends
por: Kawai, Andrew, et al.
Publicado: (2022)

Humanized mice: are we there yet?
por: Macchiarini, Francesca, et al.
Publicado: (2005)

Post-stroke inflammation and the potential efficacy of novel stem cell therapies: focus on amnion epithelial cells
por: Broughton, Brad R. S., et al.
Publicado: (2013)

Imaging predictors of poststroke depression: methodological factors in voxel-based analysis
por: Gozzi, Sophia A, et al.
Publicado: (2014)

Cell-Based Therapies for Stroke: Promising Solution or Dead End? Mesenchymal Stem Cells and Comorbidities in Preclinical Stroke Research
por: Laso-García, Fernando, et al.
Publicado: (2019)

Editorial: Cell-based Therapies for Stroke: Promising Solution or Dead End?
por: Boltze, Johannes, et al.
Publicado: (2020)

Dracunculiasis Eradication: Are We There Yet?
por: Hopkins, Donald R., et al.
Publicado: (2018)

Immunometabolism in Obese Asthmatics: Are We There Yet?
por: Periyalil, Hashim A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_975ujf4krps00mmaofi2k14t80